Trial intelligence / Profile preview

Effect of esketamine on hemodynamics and cardiac electrophysiology during general anesthesia induction

ChiCTR2100051167Phase 4Recruiting

Sponsor
Qingyuan People's Hospital
Start
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine (2 arms), sponsored by Qingyuan People's Hospital. Primary endpoints: Blood pressure, Heart rate and 2 more. Started Sep 2021; status: recruiting.

02

Drugs

esketamine

Beyond the preview

Go deeper on ChiCTR2100051167.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100051167.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call